- Home
- KVHI vs SLS Comparison
KVHI vs SLS Comparison
Compare KVHI & SLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KVHI
- SLS
- Stock Information
- Founded
- KVHI 1978
- SLS 2012
- Country
- KVHI United States
- SLS United States
- Employees
- KVHI N/A
- SLS N/A
- Industry
- KVHI Radio And Television Broadcasting And Communications Equipment
- SLS Biotechnology: Pharmaceutical Preparations
- Sector
- KVHI Technology
- SLS Health Care
- Exchange
- KVHI Nasdaq
- SLS Nasdaq
- Market Cap
- KVHI 121.2M
- SLS 100.6M
- IPO Year
- KVHI 1996
- SLS N/A
- Fundamental
- Price
- KVHI $5.84
- SLS $1.27
- Analyst Decision
- KVHI
- SLS
- Analyst Count
- KVHI 0
- SLS 0
- Target Price
- KVHI N/A
- SLS N/A
- AVG Volume (30 Days)
- KVHI 17.9K
- SLS 4.0M
- Earning Date
- KVHI 03-14-2025
- SLS 03-27-2025
- Dividend Yield
- KVHI N/A
- SLS N/A
- EPS Growth
- KVHI N/A
- SLS N/A
- EPS
- KVHI N/A
- SLS N/A
- Revenue
- KVHI $118,366,000.00
- SLS N/A
- Revenue This Year
- KVHI N/A
- SLS N/A
- Revenue Next Year
- KVHI N/A
- SLS N/A
- P/E Ratio
- KVHI N/A
- SLS N/A
- Revenue Growth
- KVHI N/A
- SLS N/A
- 52 Week Low
- KVHI $4.17
- SLS $0.77
- 52 Week High
- KVHI $6.16
- SLS $1.84
- Technical
- Relative Strength Index (RSI)
- KVHI 46.28
- SLS 50.97
- Support Level
- KVHI $5.74
- SLS $1.20
- Resistance Level
- KVHI $6.15
- SLS $1.37
- Average True Range (ATR)
- KVHI 0.14
- SLS 0.14
- MACD
- KVHI -0.04
- SLS -0.02
- Stochastic Oscillator
- KVHI 23.81
- SLS 10.94
About KVHI KVH Industries Inc.
KVH Industries Inc provide integrated, end-to-end services, software, and hardware that support its customers' need for access to the Internet, VoIP, operations content, and entertainment services. The company also provides commercially licensed entertainment, including news, sports, music, and movies, to commercial and leisure customers in the maritime, hotel, and retail markets. The Company operates in a number of geographic areas, including internationally. The Revenues are generated from international locations, mainly consisting of Singapore, Canada, European Union countries and other European countries, countries in Africa, Asia/Pacific and the Middle East, and India.
About SLS SELLAS Life Sciences Group Inc.
SELLAS Life Sciences Group Inc is a late-stage clinical biopharmaceutical company focused on the development of novel therapeutics for a broad range of cancer indications. The company's product candidates currently include galinpepimut-S, or GPS, a peptide immunotherapy directed against the Wilms tumor 1, or WT1, antigen, and GFH009, a selective small molecule cyclin-dependent kinase 9, or CDK9, inhibitor.